Who owns Immunic Inc?
- CUSIP Number: 4525ep101
Tip: Access positions for across all investors
Analyze quarterly positions in Immunic with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Immunic stock
Who bought or sold Immunic Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Standard Life Aberdeen | 8.2M | $9.2M | 0% | Mar 2026 |
|
| BVF | 7.7M | $8.5M | 0% | Mar 2026 |
|
| Avidity Partners Management | 670k | $6.4M | -86% | Mar 2026 |
|
| Vanguard Capital Management | 5.1M | $5.7M | 100% | Mar 2026 |
|
| Soleus Capital Management | 4.5M | $5.0M | 100% | Mar 2026 |
|
| Laurion Capital Management | 3.9M | $4.3M | 0% | Mar 2026 |
|
| Millennium Management | 3.8M | $4.2M | 11% | Mar 2026 |
|
| Morgan Stanley | 3.3M | $3.3M | 57% | Mar 2026 |
|
| Nantahala Capital Management | 2.5M | $2.8M | -43% | Mar 2026 |
|
| 683 Capital Management | 2.5M | $2.7M | 100% | Mar 2026 |
|
| Propel Bio Management | 2.3M | $2.6M | 100% | Mar 2026 |
|
| Geode Capital Management | 1.5M | $1.7M | 30% | Mar 2026 |
|
| Adage Capital Partners GP | 1.4M | $1.6M | 0% | Mar 2026 |
|
| Susquehanna International | 1.1M | $1.2M | 211% | Mar 2026 |
|
| Woodline Partners | 967k | $1.1M | 100% | Mar 2026 |
|
| BlackRock | 964k | $1.1M | 34% | Mar 2026 |
|
| Renaissance Technologies | 919k | $1.0M | 100% | Mar 2026 |
|
| Jane Street | 807k | $896k | 181% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 741k | $822k | 100% | Mar 2026 |
|
| Ikarian Capital | 675k | $749k | 0% | Mar 2026 |
|
| State Street Corporation | 566k | $628k | 70% | Mar 2026 |
|
| UBS Group | 523k | $580k | -3% | Mar 2026 |
|
| Hrt Financial | 493k | $547k | 100% | Mar 2026 |
|
| Simplify Asset Management | 439k | $487k | 100% | Mar 2026 |
|
| Northern Trust | 263k | $292k | 19% | Mar 2026 |
|
| Citadel Advisors | 261k | $290k | -35% | Mar 2026 |
|
| Hudson Bay Capital Management | 213k | $236k | 100% | Mar 2026 |
|
| LPL Financial | 169k | $188k | 192% | Mar 2026 |
|
| OMERS Administration Corporation | 168k | $187k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 150k | $166k | 100% | Mar 2026 |
|
| Bank of America Corporation | 144k | $160k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 122k | $135k | 468554% | Mar 2026 |
|
| Virtu Financial | 113k | $126k | 100% | Mar 2026 |
|
| Qube Research & Technologies | 112k | $124k | 100% | Mar 2026 |
|
| Strategies Wealth Advisors | 100k | $111k | 0% | Mar 2026 |
|
| HB Wealth Management | 92k | $102k | 0% | Mar 2026 |
|
| Mml Investors Services | 91k | $101k | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 85k | $94k | 240% | Mar 2026 |
|
| Two Sigma Investments | 67k | $75k | -12% | Mar 2026 |
|
| Cambridge Investment Research Advisors | 49k | $54k | 100% | Mar 2026 |
|
| Brevan Howard Capital Management | 46k | $51k | 100% | Mar 2026 |
|
| Creative Planning | 35k | $39k | 0% | Mar 2026 |
|
| Graham Capital Management | 33k | $37k | 100% | Mar 2026 |
|
| Tower Research Capital | 33k | $37k | 756% | Mar 2026 |
|
| Vanguard Global Advisers | 32k | $35k | 100% | Mar 2026 |
|
| XTX Topco | 31k | $34k | -86% | Mar 2026 |
|
| ADAR1 Capital Management | 30k | $0 | 100% | Mar 2026 |
|
| Quadrature Capital | 30k | $33k | 100% | Mar 2026 |
|
| Bank of New York Mellon | 28k | $32k | -7% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 28k | $31k | 100% | Mar 2026 |
|
| Scientech Research | 27k | $30k | 100% | Mar 2026 |
|
| CTC Alternative Strategies | 24k | $27k | 100% | Mar 2026 |
|
| CI Private Wealth | 22k | $25k | 100% | Mar 2026 |
|
| Lincoln Capital | 20k | $23k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 20k | $22k | 100% | Mar 2026 |
|
| Axq Capital | 18k | $20k | 100% | Mar 2026 |
|
| Balboa Wealth Partners | 12k | $13k | 0% | Mar 2026 |
|
| Baader Bank | 11k | $8.2k | 100% | Mar 2026 |
|
| Commonwealth Equity Services | 10k | $12k | 100% | Mar 2026 |
|
| Private Advisor | 10k | $11k | 0% | Mar 2026 |
|
| Crescent Grove Advisors | 10k | $11k | 0% | Mar 2026 |
|
| CWM | 8.6k | $9.6k | 0% | Mar 2026 |
|
| SBI Securities | 3.8k | $4.2k | 4% | Mar 2026 |
|
| Royal Bank of Canada | 3.0k | $3.0k | 100% | Mar 2026 |
|
| Barclays | 2.4k | $2.7k | 498% | Mar 2026 |
|
| Group One Trading | 1.7k | $1.9k | 100% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 1.5k | $1.7k | 0% | Mar 2026 |
|
| Rockefeller Capital Management | 1.0k | $1.1k | 0% | Mar 2026 |
|
| Wells Fargo & Company | 900.00 | $998.730000 | 0% | Mar 2026 |
|
| FMR | 455.00 | $505.004500 | 100% | Mar 2026 |
|
| SHP Wealth Management | 140.00 | $154.994000 | 180% | Mar 2026 |
|
| Smartleaf Asset Management | 21.00 | $21.999600 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 3.00 | $3.000000 | 100% | Mar 2026 |
|
Who sold out of Immunic?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Colony | Dec 2025 | 2.6M | $2.3M |
| Marshall Wace | Dec 2025 | 1.0M | $541k |
| GSA Capital Partners | Dec 2025 | 528k | $282k |
| Squarepoint Ops | Dec 2025 | 353k | $188k |
| Connective Capital Management | Dec 2025 | 301k | $161k |
| Seven Fleet Capital Management | Dec 2025 | 155k | $83k |
| Boothbay Fund Management | Dec 2025 | 131k | $70k |
| Caption Management | Dec 2025 | 50k | $27k |
| Bridgeway Capital Management | Dec 2025 | 40k | $21k |
| Marex Group | Dec 2025 | 33k | $18k |
| Intl Fcstone | Dec 2025 | 21k | $11k |
| Level Four Advisory Services | Dec 2025 | 11k | $5.8k |
| PFG Investments | Dec 2025 | 11k | $5.6k |
| Retirement Planning Group | Dec 2025 | 10k | $5.6k |
| Dynamic Advisors Solutions | Mar 2026 | 10k | $11k |
| Addison Advisors | Dec 2025 | 5.2k | $2.8k |
| Hanson McClain Advisors | Dec 2025 | 842.00 | $449.964800 |
| Caldwell Sutter Capital | Dec 2025 | 3.00 | $2.000100 |